Häftad, Engelska, 2027
Therapeutic Horizons in Non-Small Cell Lung Cancer
AI-Driven Innovations in Diagnosis and Treatment
Av Vaishali Aggarwal, Vivek Kumar Garg, Harpal Buttar, Neelam Goel
1868 kr
Kommande
Beskrivning
- Provides a detailed overview of AI and machine learning applications in NSCLC diagnostics and therapeutics
- Integrates molecular biology, clinical workflows, and technological innovations for a translational approach
- Highlights global perspectives, disparities, and ethical considerations in AI-driven lung cancer management
Produktinformation
- Utgivningsdatum: 2027-06-01
- Mått: 191 x 235 x undefined mm
- Format: Häftad
- Språk: Engelska
- Antal sidor: 330
- Förlag: Elsevier Science
- ISBN: 9780443512100
Utforska kategorier
Mer om författaren
Vaishali Aggarwal, Ph.D. at PU – IIT Ropar Regional Accelerator for Holistic Innovations, Northern S&T Cluster, Chandigarh, India, specializing in immuno-oncology research. With more than a dozen years of experience, her work focuses on immunotherapeutics, including checkpoint inhibitors like PD1 and LAG3. She investigates tumor immunology and the tumor microenvironment, exploring how immune and cancer cells interact and respond to therapies. Dr. Aggarwal has trained at PGIMER and the University of Pittsburgh and has authored numerous research articles. She has extensive mentorship and leadership experience spanning several years. Her research contributions have been widely recognized, with numerous citations and book chapters to her name, reflecting her significant impact in the field. Dr. Vivek Kumar Garg is an Associate Professor in the Department of Medical Lab Sciences at Rayat Bahra University, India. He earned his PhD in Neurology from the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, and holds an M.Sc. in Medical Biochemistry. His research interests include cancer biology, genomics, epilepsy and neurological disorders, artificial intelligence in healthcare, biomarkers, clinical biochemistry, cardiovascular diseases, diabetes mellitus, and chronic kidney disease. His work focuses on the application of molecular, biochemical, and computational approaches to biomedical and translational research. He has contributed to research publications, academic books, and scholarly activities and has served as a reviewer and editorial board member for several international journals. Harpal S. Buttar, PhD, is Adjunct Professor in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Canada, and also serves as Visiting Professor at Guru Nanak Dev University, India, and Honorary Professor at Amity University, India. He previously worked for more than four decades as a Senior Research Scientist and Assessment Officer in the Therapeutic Products Directorate of Health Canada. His research and professional interests include pharmacology, nutrition, functional foods, dietary interventions, lifestyle approaches to the prevention of cardiovascular disease, obesity, and diabetes, and the safety of drug interactions with herbal products and fruit juices. Dr. Buttar has contributed extensively to biomedical research through scholarly publications, book chapters, and international collaborations. He has served on the editorial boards of scientific journals, acted as an external examiner for postgraduate research degrees, and delivered invited lectures and seminars internationally. He is a Fellow of the International College of Nutrition and the International Academy of Cardiovascular Sciences.Neelam Goel, Ph.D., is an Assistant Professor in the Department of Information Technology at UIET, Panjab University, Chandigarh. With over fifteen years of experience, her expertise lies in bioinformatics, biomedical signal and image processing, gene prediction, cancer multi-omics, and neurodegenerative disorders. She has authored dozens of publications across international journals, conferences, and book chapters.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.